A World Free From the Fear of Cancer
We are a global community of advocates, patients, doctors, researchers, caregivers, and others dedicated to improving the lives of people affected by cancer.
About Hero Image
Conquer Cancer's charity logos; Better Business Bureau, GuideStar 2020, Charity Navigator
Recognized with High Ratings

Conquer Cancer is proud to be recognized with the highest ratings as a 4-Star Charity on Charity Navigator, Better Business Bureau Accredited Charity and Platinum status from Guidestar.

About ASCO Hero
Our Mission
Funding Breakthrough Research and Sharing Cutting-Edge Knowledge

Conquer Cancer, the ASCO Foundation, funds research for every cancer, every patient, everywhere. In 1964, seven oncologists created the American Society of Clinical Oncology, now a global network of nearly 45,000 cancer professionals. As ASCO’s foundation, Conquer Cancer supports groundbreaking research and education so both doctors and patients have the resources they need.

Our Leadership

Meet the people leading our team and driving our initiatives. 

Nancy R. Daly, MS, MPH
Nancy R. Daly, MS, MPH
Chief Executive Officer and Executive Vice-President
Adrien Dickerson, MBA
Adrien Dickerson, MBA
Chief Operating Officer/Division Director
Eileen Melnick
Eileen Melnick
Director, Grants & Awards
Melissa Tai
Melissa Tai
General Counsel
Carolyn J. Whitehead
Carolyn J. Whitehead
Division Director, Individual Philanthropy
Headshot of Shaun Quigley, Conquer Cancer's Marketing and Communications Division Director
Shaun Quigley
Division Director, Marketing & Communications

Board of Directors

Get to the know the experts guiding our vision. 

Financial Information
Annual Reports, Form 990s and Audited Financial Documents

Conquer Cancer thoughtfully manages the funds of individuals, corporations and other organizations to further our vision of creating a world free from the fear of cancer. 

Your donation supports the brightest minds in cancer research working on treatments and cures for every cancer, every patient, everywhere.